Brand-specific enhanced safety surveillance of GSK’s Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season (Human Vaccines and Immunotherapeutics, 2020)

(untitled) - de Lusignan, S; Damaso, S; Ferreira, F; Byford, R; McGee, C; Pathirannehelage, S; Shende, V; Yonova, I; Schmidt, A; Schuind, A; Dos Santos. G